Physician

Harvinder Paul Singh, M.D.

According to 2025 Medicare claims, Harvinder Singh, M.D. (NPI: 1861495558) practices cardiology in the Grand Rapids-Wyoming-Kentwood, MI market, with the plurality of this provider's patient population coming from Kent, MI. This provider's primary affiliated billing organization is WEST MICHIGAN CARDIOLOGY, PC (NPI: 1780770859; TIN: 38-3009528) and primary practice location at 49525-7051. Singh is affiliated with the West Michigan Accountable Care Organization, LLC (ACO ID: A4626), participating under the MSSP model.

Singh's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 633 traditional Medicare patients, billed 16,212 HCPCS/CPT codes, and received $475,138 in Medicare payments. The top billing code was 78452 (Nuclear medicine studies of heart muscle at rest and with stress and spect). Part D data shows 957 prescription claims across 318 beneficiaries totaling $164,446 in drug costs, led by Repatha Sureclick (Evolocumab). 2015 DME data shows 12 claims. Open Payments data shows 90 records totaling $4,258. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $567,409 to $475,138. Similarly, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $792,763 to $164,446. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	998	16,294	$567,409
2016	1,036	17,904	$543,230
2017	1,074	16,664	$585,749
2018	923	14,657	$461,816
2019	929	13,967	$474,721
2020	738	11,360	$398,996
2021	665	10,327	$401,306
2022	634	10,937	$377,698
2023	596	10,464	$309,795
2024	633	16,212	$475,138

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	999	7,980	$792,763
2016	997	7,779	$818,907
2017	786	2,858	$294,956
2018	930	4,668	$588,461
2019	931	4,820	$679,506
2020	575	1,768	$249,765
2021	511	1,765	$285,010
2022	477	1,435	$287,014
2023	345	920	$140,358
2024	318	957	$164,446

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	12	$376
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
78452	Nuclear medicine studies of heart muscle at rest and with stress and spect	107	107	$329
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	185	186	$128
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	378	770	$94
93015	Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician	108	108	$45
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	255	318	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Repatha Sureclick	Evolocumab	38	2,351	$44,098
Eliquis	Apixaban	34	2,220	$41,691
Jardiance	Empagliflozin	15	930	$17,387
Entresto	Sacubitril/Valsartan	16	840	$16,449
Xarelto	Rivaroxaban	13	750	$11,085

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	90	$4,258	Boston Scientific Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Harvinder Paul Singh, M.D.?

Tedicare shows public-source Medicare data for Harvinder Paul Singh, M.D. (NPI 1861495558), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Harvinder Paul Singh, M.D. have ACO affiliation data?

Harvinder Paul Singh, M.D. is shown with ACO affiliation data for West Michigan Accountable Care Organization, LLC (MSSP, ACO ID A4626).

What billing organization is linked to Harvinder Paul Singh, M.D.?

Harvinder Paul Singh, M.D. is linked to WEST MICHIGAN CARDIOLOGY, PC (billing NPI 1780770859) in the available physician profile data.

Does Harvinder Paul Singh, M.D. have Open Payments data?

Harvinder Paul Singh, M.D. has 90 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.